<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17</volume><submitter>Savas S</submitter><funding>newfoundland and labrador</funding><funding>astrazeneca canada</funding><funding>Marathon of Hope Cancer Centres Network</funding><funding>terry fox research institute</funding><funding>mitacs</funding><funding>Atlantic Cancer Consortium</funding><funding>new brunswick innovation foundation</funding><funding>pfizer canada</funding><funding>research nova scotia</funding><funding>New Brunswick Health Research Foundation</funding><funding>beatrice hunter cancer research institute</funding><funding>roche</funding><funding>memorial university of newfoundland</funding><funding>qeii foundation</funding><pubmed_abstract>&lt;h4>Introduction and objectives&lt;/h4>Public partnerships, engagement, and outreach are essential for meaningful knowledge dissemination and exchange activities in public settings. In 2024, we formed the Atlantic Cancer Consortium Patient Advisory Committee (ACC PAC). In March 2025, the ACC PAC delivered a successful public conference on precision medicine and cancer. Our primary objective is to share the perspectives gained, lessons learnt, impact of the event, and recommendations for future public conferences and engagement.&lt;h4>Methods&lt;/h4>Conference topics were identified by the ACC PAC. Speaker selection and conference promotion were done using various approaches and/or tools. The WebEx virtual platform was used to deliver the conference. This conference was open to all members of the pu</pubmed_abstract><journal>Journal of primary care &amp; community health</journal><pagination>21501319261420572</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12924974</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Patient Advisory Committee Engagement in a Precision Medicine-Focused Public Oncology Conference: Case Report of Lessons Learned.</pubmed_title><pmcid>PMC12924974</pmcid><pubmed_authors>Skardasi G</pubmed_authors><pubmed_authors>LeBlanc G</pubmed_authors><pubmed_authors>Martinez MF</pubmed_authors><pubmed_authors>MacInnis C</pubmed_authors><pubmed_authors>Coish J</pubmed_authors><pubmed_authors>Curtis AA</pubmed_authors><pubmed_authors>King J</pubmed_authors><pubmed_authors>Hyde A</pubmed_authors><pubmed_authors>Savas S</pubmed_authors><pubmed_authors>Donovan Whitty J</pubmed_authors><pubmed_authors>Pausche B</pubmed_authors><pubmed_authors>Corbett C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patient Advisory Committee Engagement in a Precision Medicine-Focused Public Oncology Conference: Case Report of Lessons Learned.</name><description>&lt;h4>Introduction and objectives&lt;/h4>Public partnerships, engagement, and outreach are essential for meaningful knowledge dissemination and exchange activities in public settings. In 2024, we formed the Atlantic Cancer Consortium Patient Advisory Committee (ACC PAC). In March 2025, the ACC PAC delivered a successful public conference on precision medicine and cancer. Our primary objective is to share the perspectives gained, lessons learnt, impact of the event, and recommendations for future public conferences and engagement.&lt;h4>Methods&lt;/h4>Conference topics were identified by the ACC PAC. Speaker selection and conference promotion were done using various approaches and/or tools. The WebEx virtual platform was used to deliver the conference. This conference was open to all members of the pu</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan-Dec</publication><modification>2026-07-16T15:18:26.969Z</modification><creation>2026-07-11T03:07:44.837Z</creation></dates><accession>S-EPMC12924974</accession><cross_references><pubmed>41711371</pubmed><doi>10.1177/21501319261420572</doi></cross_references></HashMap>